The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Accelerator™ Drug Development solutions support your aspiration to get treatments to patients faster.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Characterizing viral vector products and associated impurities is critical to ensuring the safety and efficacy of viral vector therapies. View the following infographic for tips and aspects to consider for robust viral vector analytical characterization, including strategies to overcome challenges in assessing impurities and defining critical quality attributes (CQAs).